Latest Stories
Uncategorized
Eli Lilly Expands AI Drug Discovery Bet With $2.75 Billion Insilico Medicine Deal
Eli Lilly signed a deal worth up to $2.75 billion with Insilico Medicine to develop new drugs using AI, one of 2026's largest AI drug discovery partnerships.
Uncategorized
WellSpan Health Expands Hippocratic AI Deal to Platform-Wide Use Across Every Care Setting
WellSpan Health expanded its partnership with Hippocratic AI on July 30, 2026 into a platform-wide, multi-year deal covering inbound, outbound, ambulatory, and inpatient care, moving its Ana voice agent beyond scheduling into clinical navigation.
Uncategorized
AstraZeneca Signs Up to $1.5 Billion AI Drug-Discovery Deal With insitro to Target MASH and Cardiomyopathies
AstraZeneca signed an AI drug-discovery deal with insitro on October 15, 2026 worth up to $1.5 billion, targeting MASH and cardiomyopathies using insitro's Virtual Human machine-learning platform.
Uncategorized
Chai Discovery Raises $400 Million at $3.8 Billion Valuation as AI Drug Design Reaches Eli Lilly and Pfizer
Chai Discovery has raised a $400 million Series C round led by Index Ventures at a $3.8 billion valuation, nearly tripling its worth from seven months earlier as its AI-designed antibodies move into partnerships with Eli Lilly and Pfizer.
In-Depth
Uncategorized
OpenAI Acquires Health-Tech Startup Torch to Build ‘Unified Medical Memory’ for ChatGPT Health
OpenAI has acquired Torch, a four-person health-tech startup building a unified patient data layer for AI systems, in a deal reported at $60 million to $100 million as part of its push into consumer health products.
Uncategorized
University of Texas System to Deploy Generative AI Across All Health Institutions With Qualified Health
The University of Texas System is rolling out a generative AI chat platform and staff productivity agents across its health institutions in partnership with Qualified Health, one of the broadest academic-medicine AI deployments announced in 2026.
Uncategorized
AstraZeneca and Oracle Launch Global AI Collaboration to Speed Clinical Trials and Early Diagnosis
AstraZeneca and Oracle announced a global AI collaboration on October 20, 2026 to speed clinical trial recruitment and early diagnosis, starting with a hypertension pilot in Abu Dhabi built on deidentified real-world data.
Uncategorized
Swedish MASAI Trial Finds AI-Supported Mammography Catches More Cancers Without More False Alarms
Sweden's randomized MASAI trial found AI-supported mammography improved detection of clinically relevant breast cancers without raising false-positive rates, bolstering the evidence base for AI-assisted screening.
Uncategorized
New AI Model Automates Cervical Cancer Screening Reads Across 9,000-Plus Slides
A new AI system called Cytoreader-Fusion automated dual-stain cervical cancer screening reads across more than 9,000 slides in a retrospective study, part of a broader wave of AI cancer-screening research in 2026.
